Healthcare provider profile · identity verified

Todd G. Gottschalk, DO

Internal Medicine · SPOKANE, WA · NPI 1457456873

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	678	194
Losartan Potassium	Losartan Potassium	552	155
Levothyroxine Sodium	Levothyroxine Sodium	497	131
Amlodipine Besylate	Amlodipine Besylate	419	113
Lisinopril	Lisinopril	388	108
Omeprazole	Omeprazole	381	98
Metformin Hcl	Metformin Hcl	289	84
Hydrochlorothiazide	Hydrochlorothiazide	244	68
Gabapentin	Gabapentin	219	55
Rosuvastatin Calcium	Rosuvastatin Calcium	216	53
Tamsulosin Hcl	Tamsulosin Hcl	209	60
Pantoprazole Sodium	Pantoprazole Sodium	183	46
Metformin Hcl Er	Metformin Hcl	182	50
Potassium Chloride	Potassium Chloride	180	57
Jardiance	Empagliflozin	168	39
Furosemide	Furosemide	166	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	166	39
Allopurinol	Allopurinol	152	41
Trazodone Hcl	Trazodone Hcl	148	42
Metoprolol Succinate	Metoprolol Succinate	147	47
Duloxetine Hcl	Duloxetine Hcl	145	35
Lovastatin	Lovastatin	141	35
Tramadol Hcl	Tramadol Hcl	139	29
Simvastatin	Simvastatin	137	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	124	33
Sertraline Hcl	Sertraline Hcl	114	30
Escitalopram Oxalate	Escitalopram Oxalate	109	26
Lorazepam	Lorazepam	109	19
Albuterol Sulfate Hfa	Albuterol Sulfate	108	36
Meloxicam	Meloxicam	102	38
Fluticasone Propionate	Fluticasone Propionate	91	28
Pravastatin Sodium	Pravastatin Sodium	88	29
Citalopram Hbr	Citalopram Hydrobromide	83	22
Metoprolol Tartrate	Metoprolol Tartrate	83	23
Montelukast Sodium	Montelukast Sodium	83	24
Bupropion Xl	Bupropion Hcl	80	19
Clopidogrel	Clopidogrel Bisulfate	80	20
Glimepiride	Glimepiride	80	20
Ezetimibe	Ezetimibe	77	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	20
Atenolol	Atenolol	72	18
Tizanidine Hcl	Tizanidine Hcl	72	17
Glipizide Er	Glipizide	70	23
Xarelto	Rivaroxaban	69	19
Alendronate Sodium	Alendronate Sodium	66	22
Spironolactone	Spironolactone	64	21
Carvedilol	Carvedilol	63	15
Acetaminophen-Codeine	Acetaminophen With Codeine	62	suppressed
Pregabalin	Pregabalin	60	15
Ipratropium Bromide	Ipratropium Bromide	59	16
Fluoxetine Hcl	Fluoxetine Hcl	56	12
Ozempic	Semaglutide	55	12
Eliquis	Apixaban	54	15
Famotidine	Famotidine	52	15
Memantine Hcl	Memantine Hcl	49	11
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Baclofen	Baclofen	42	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Prednisone	Prednisone	40	30
Alprazolam	Alprazolam	39	14
Amitriptyline Hcl	Amitriptyline Hcl	39	11
Fenofibrate	Fenofibrate	39	suppressed
Olanzapine	Olanzapine	38	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	36	suppressed
Chlorthalidone	Chlorthalidone	35	11
Quetiapine Fumarate	Quetiapine Fumarate	35	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	12
Buspirone Hcl	Buspirone Hcl	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Aripiprazole	Aripiprazole	32	suppressed
Cephalexin	Cephalexin	32	28
Lamotrigine	Lamotrigine	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	11
Ibandronate Sodium	Ibandronate Sodium	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Buprenorphine	Buprenorphine	28	suppressed
Naproxen	Naproxen	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Ondansetron Odt	Ondansetron	27	15
Valacyclovir	Valacyclovir Hcl	27	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Finasteride	Finasteride	25	suppressed
Nystatin	Nystatin	24	suppressed
Topiramate	Topiramate	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Estradiol	Estradiol	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Testosterone	Testosterone	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Valsartan	Valsartan	16	suppressed
Azithromycin	Azithromycin	15	15
Celecoxib	Celecoxib	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Victoza 3-Pak	Liraglutide	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Invokana	Canagliflozin	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Seroquel Xr	Quetiapine Fumarate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error